云南白药联合生长抑素及泮托拉唑治疗肝硬化合并上消化道出血的效果观察

赵晶凤; 刘群; 王秀艳; 张扬; 梁丽薇; 甘雨

doi:10.3969/j.issn.1001-5256.2018.01.019

云南白药联合生长抑素及泮托拉唑治疗肝硬化合并上消化道出血的效果观察

DOI: 10.3969/j.issn.1001-5256.2018.01.019

1. 沈阳二四二医院消化内科
2. 辽宁省中医药研究院

基金项目:

辽宁省科技厅自然科学基金(201202113)；

详细信息

中图分类号: R573.2;R575.2
计量
- 文章访问数: 2177
- HTML全文浏览量: 90
- PDF下载量: 436
- 被引次数: 0
出版历程
- 出版日期: 2018-01-20

Efficacy of Yunnan white medicinal powder combined with somatostatin and pantoprazole in treatment of liver cirrhosis complicated by upper gastrointestinal bleeding and its effect on inflammatory factors

Department of Gastroenterology, Shenyang 242 Hospital, Shenyang 110034, China

Research funding:

摘要

摘要:
目的探讨云南白药联合生长抑素及泮托拉唑治疗肝硬化合并上消化道出血的临床效果及对炎症因子的影响。方法选取2016年4月-2017年3月沈阳二四二医院收治的肝硬化合并上消化道出血患者150例,随机分为观察组和对照组各75例。对照组给予注射用生长抑素+注射用泮托拉唑钠治疗,观察组在对照组基础上加用云南白药进行治疗。观察两组患者的临床疗效、输血量、止血时间、住院时间及血红蛋白变化情况,并比较两组患者治疗前后血清中超敏C反应蛋白（hs-CRP）、IL-6水平的变化。计量资料组间比较采用t检验,计数资料组间比较采用χ2检验,等级资料采用Ridit分析u检验。结果观察组患者的输血量、止血时间和住院时间均明显低于对照组（t值分别为6.357、7.360、4.469,P值均<0.01）,治疗后血红蛋白水平明显高于对照组（t=4.042,P<0.01）。观察组患者治疗总有效率高于对照组,差异有统计学意义（96.00%vs 85.33%,u=2.564,P<0.05）。经治疗后两组患者血清hs-CRP、IL-6水平均明显降低（t值分别为14.240、6.943、35....
- 肝硬化 /
- 上胃肠道 /
- 出血 /
- 云南白药 /
- 生长抑素 /
- 泮托拉唑 /
- 治疗结果
Abstract:
Objective To investigate the efficacy of Yunnan white medicinal powder combined with somatostatin and pantoprazole in the treatment of liver cirrhosis complicated by upper gastrointestinal bleeding and its effect on inflammatory factors. Methods A total of 150 patients with liver cirrhosis complicated by upper gastrointestinal bleeding who were admitted to Shenyang 242 Hospital from April 2016 to March 2017 were enrolled and randomly divided into observation group and control group, with 75 patients in each group. The patients in the control group were given somatostatin for injection + pantoprazole sodium for injection, and those in the observation group were given Yunnan white medicinal powder in addition to the treatment for the control group. The two groups were observed and compared in terms of clinical outcome, blood transfusion volume, time to hemostasis, length of hospital stay, and change in hemoglobin, as well as the changes in the serum levels of high-sensitivity C-reactive protein ( hs-CRP) and interleukin-6 ( IL-6) after treatment. The t-test was used for comparison of continuous data between groups, the chi-square test was used for comparison of categorical data between groups, and the Ridit analysis and the u test were used for ranked data of clinical outcome. Results Compared with the control group, the observation group had a significantly lower blood transfusion volume and significantly shorter time to hemostasis and length of hospital stay ( t = 6. 357, 7. 360, and 4. 469, all P < 0. 01) , as well as a significantly higher level of hemoglobin after treatment ( t = 4. 042, P < 0. 01) . The observation group had a significantly higher overall response rate than the control group ( 96. 00% vs 85. 33% , u = 2. 564, P < 0. 05) . Both groups had significant reductions in the serum levels of hs-CRP and IL-6 after treatment ( t = 14. 240, 6. 943, 35. 277, and 17. 764, all P < 0. 01) , and the observation group had a significantly higher level of hs-CRP and IL-6 than the control group after treatment ( t = 7. 984 and 18. 946, both P < 0. 01) . Conclusion Yunnan white medicinal powder combined with somatostatin and pantoprazole has a marked clinical effect in the treatment of liver cirrhosis complicated by upper gastrointestinal bleeding and can reduce blood transfusion volume, shorten the time to hemostasis and length of hospital stay, and reduce the serum levels of hs-CRP and IL-6.
- liver cirrhosis /
- upper gastrointestinal tract /
- hemorrhage /
- YUNNAN BAI YAO /
- somatostatin /
- pantoprazole /
- treatment outcome

HTML全文

参考文献(16)

[1]HUANG X, YANG L.Clinical observation of different doses of acetic octreotide in the treatment of esophagogastric varicose hemorrhage in patients with liver cirrhosis[J].China Pharm, 2014, 25 (16) :1478-1480. (in Chinese) 黄欣, 杨柳.不同剂量醋酸奥曲肽治疗肝硬化食管胃静脉曲张破裂出血的临床观察[J].中国药房, 2014, 25 (16) :1478-1480.

[2]LI JJ, CHEN DR.Meta analysis on effect of terlipressin and somatostatin in treatment of acute gastroesophageal variceal hemorrhage[J].J Mod Med Health, 2016, 32 (2) :170-172. (in Chinese) 李佳婧, 陈道荣.特利加压素与生长抑素治疗食管胃底静脉曲张出血的疗效meta分析[J].现代医药卫生, 2016, 32 (2) :170-172.

[3] Chinese Society of Gastroenterology, Chinese Society of Hepatology, Chinese Society of Endoscopy.Consensus on prevention and treatment for gastroesophageal varices and variceal hemorrhage in liver cirrhosis[J].Chin J Hepatol, 2008, 16 (8) :564-570. (in Chinese) 中华医学会消化病学分会, 中华医学会肝病学分会, 中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治共识[J].中华肝脏病杂志, 2008, 16 (8) :564-570.

[4]MOON AM, DOMINITZ JA, IOANNOU GN, et al.Use of antibiotics among patients with cirrhosis and upper gastrointestinal bleeding is associated with reduced mortality[J].Clin Gastroenterol Hepatol, 2016, 14 (11) :1629-1637.

[5]DENG H, QI XS, GUO XZ.UK fuidelines on the management of variceal haemorrhage in cirrhotic patients (2015) :an excerpt of recommendations[J].J Clin Hepatol, 2015, 31 (6) :852-854. (in Chinese) 邓晗, 祁兴顺, 郭晓钟.《2015年英国肝硬化静脉曲张出血防治指南》摘译[J].临床肝胆病杂志, 2015, 31 (6) :852-854.

[6]XIA YL, ZHANG CQ, WANG GC, et al.Individual and combined effects of octreotide and terlipressin on hepatic venous pressure gradient in cirrhotic patients[J].J Clin Hepatol, 2015, 31 (2) :214-218. (in Chinese) 夏玉莲, 张春清, 王广川, 等.奥曲肽和特利加压素单用或联用对肝硬化患者肝静脉压力梯度的影响[J].临床肝胆病杂志, 2015, 31 (2) :214-218.

[7]CHANG H, WANG YZ.Clinical observation on somatostatin combined pantoprazole in treating severe non-variceal upper gastrointestinal hemorrhage[J].Mod Med J China, 2014, 16 (1) :45-47. (in Chinese) 常红, 王银章.生长抑素联合泮托拉唑治疗非食管胃底静脉曲张性上消化道出血疗效观察[J].中国现代医药杂志, 2014, 16 (1) :45-47.

[8]ZHI HF.Clinical analysis of somatostatin combined omeprazole in treatment of stomach bleeding caused by liver cirrhosis portal hypertension[J].J North Pharm, 2013, 10 (5) :41. (in Chinese) 智恒峰.生长抑素联合奥美拉唑治疗肝硬化门脉高压性胃出血临床观察[J].北方药学, 2013, 10 (5) :41.

[9]NEOPHYTOU H, MATHIEU A, MONSEU M, et al.Upper gastrointestinal haemorrhage due to a small extra-papillary duodenal neuroendocrine tumour expressing somatostatin[J].Ann Endocrinol (Paris) , 2015, 76 (6) :697-701.

[10]GAO CG, XIE F, FENG YD.Effect of somatostatin combined with pantoprazole in treatment of liver cirrhosis with upper gastrointestinal hemorrhage[J].J Clin Hepatol, 2016, 32 (2) :284-287. (in Chinese) 高成广, 谢峰, 冯亚东.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的疗效观察[J].临床肝胆病杂志, 2016, 32 (2) :284-287.

[11]ALHAZZANI W, GUYATT G, ALSHAHRANI M, et al.Withholding pantoprazole for stress ulcer prophylaxis in critically Ill patients:a pilot randomized clinical trial and meta-analysis[J].Crit Care Med, 2017, 45 (7) :1121-1129.

[12]SUN Y, REN TS, ZHAO QC.Analysis of drug use in 537 patients with decompensated liver cirrhosis[J].Trauma Crit Med, 2016, 4 (4) :229-235. (in Chinese) 孙滢, 任天舒, 赵庆春.肝硬化失代偿期537例患者用药分析[J].创伤与急危重病医学, 2016, 4 (4) :229-235.

[13]WU J, XIAO X.Clinical observation of combination of Pantoprazole and Yunnanbaiyao on the treatment of upper gastrointestinal bleeding[J].Sichuan Med J, 2012, 33 (11) :1971-1972. (in Chinese) 吴剑, 肖霞.泮托拉唑联合云南白药治疗上消化道出血的临床观察[J].四川医学, 2012, 33 (11) :1971-1972.

[14]KWAK MS, CHA JM, HAN YJ, et al.The clinical outcomes of lower gastrointestinal bleeding are not better than those of upper gastrointestinal bleeding[J].J Korean Med Sci, 2016, 31 (10) :1611-1616.

[15]ANSARIN K, RASHIDI F, NAMDAR H, et al.Echocardiographic evaluation of the relationship between inflammatory factors (IL6, TNFα, hs-CRP) and secondary pulmonary hypertension in patients with COPD.A cross sectional study[J].Pneumologia, 2015, 64 (3) :31-35.

[16]MA G, GUO J.Clinical observation of treat gastrointestinal bleeding with somatostatin combined ulinastatin and analysis its effect on inflammatory factors[J].J Clin Exp Med, 2016, 15 (11) :1081-1083. (in Chinese) 马刚, 郭娟.生长抑素联合乌司他丁治疗消化道出血的临床疗效及其对炎症因子的影响[J].临床和实验医学杂志, 2016, 15 (11) :1081-1083.

施引文献

资源附件(0)

访问统计